Ropivacaine: A Review on the Pharmacological Features, Therapeutic Efficacy and Side-effects When used for Caudal Epidural Analgesia
Published: August 1, 2022 | DOI: https://doi.org/10.7860/JCDR/2022/56478.16687
Shilpa Shankar, Vivek Chakole
1. Junior Resident, Department of Anesthesiology, Jawaharlal Nehru Medical College, Wardha, Maharashtra, India.
2. Professsor and Head, Department of Anesthesiology, Jawaharlal Nehru Medical College, Wardha, Maharashtra, India.
Correspondence
Shilpa Shankar,
Junior Resident, Department of Anaesthesiology Jawaharlal Nehru Medical College, Dmims, Sawangi Meghe, Wardha, Maharashtra, India.
E-mail: shilshank@gmail.com
Inadequate post operative pain treatment can lead to clinical and psychological changes, as well as increased morbidity, mortality, and financial burden, all of which can influence quality of life. A review of the pharmacological characteristics, therapeutic efficacy in delivering postoperative analgesia, and side-effects of Ropivacaine is presented in this article. Motor blockade is an unwanted effect during the post operative period. The fear of side-effects and hemodynamic instability caused by the most of the analgesic drugs are the challenges faced in providing effective post operative analgesia in children. Ropivacaine has lesser cardiotoxic effects, lesser motor blockade and minimal side-effects as compared to bupivacaine. These properties make it a promising drug for pediatric caudal analgesia and forms a cost-effective method by decreasing the requirement of systemic analgesics, morbidity and improving the life quality postoperatively.
[
FULL TEXT ] | [ PDF]